In a research environment dominated by reductionist approaches to brain disease mechanisms, gene network analysis provides a complementary framework in which to tackle the complex dysregulations that occur in neuropsychiatric and other neurological disorders. Gene-gene expression correlations are a common source of molecular networks because they can be extracted from high-dimensional disease data and encapsulate the activity of multiple regulatory systems. However, the analysis of gene coexpression patterns is often treated as a mechanistic black box, in which looming 'hub genes' direct cellular networks, and where other features are obscured. By examining the biophysical bases of coexpression and gene regulatory changes that occur in disease, recent studies suggest it is possible to use coexpression networks as a multi-omic screening procedure to generate novel hypotheses for disease mechanisms. Because technical processing steps can affect the outcome and interpretation of coexpression networks, we examine the assumptions and alternatives to common patterns of coexpression analysis and discuss additional topics such as acceptable datasets for coexpression analysis, the robust identification of modules, disease-related prioritization of genes and molecular systems and network meta-analysis. To accelerate coexpression research beyond modules and hubs, we highlight some emerging directions for coexpression network research that are especially relevant to complex brain disease, including the centrality-lethality relationship, integration with machine learning approaches and network pharmacology.
Common brain diseases include dysfunction at the levels of genes, cells, brain regions and feedback between these networks at multiple biological scales. The overlapping activity and regulation of many systems can obscure the root pathogenic mechanisms when examining any single measurement. For example, major depressive disorder and other neuropsychiatric disorders involve changes in multiple genes, each conferring small and incremental risk that potentially converge in deregulated biological pathways, cellular functions and local circuit changes, eventually scaling up to brain region pathophysiology (Belmaker & Agam 2008; Sibille & French 2013) . In these conditions, when several hundred molecules in multiple biological pathways may be legitimately linked to pathogenesis, disease models face competing demands for conceptual clarity and biological accuracy.
What strategies are available to transform data from multiscale brain diseases into testable hypotheses in cellular or animal disease models? Molecular pathway analysis of differentially expressed genes obtained from post-mortem tissue is constrained by the current state of molecular knowledge and does not provide a prioritization of molecules within the affected pathways. Network biology -an emerging discipline within systems biology -can catalog, integrate and quantify genome-scale molecular interactions, and by doing so can identify critical network features that are relevant to disease processes (Ma'ayan 2009; Vidal et al. 2011) . However, validating phenotype-level predictions from these brain-based models remains challenging. Neuronal simulations can accurately reproduce the dynamics of local and inter-regional brain networks (Izhikevich 2007) , but very rarely incorporate gene-regulation of ion-channels. At the level of genes, dynamic modeling approaches, such as probabilistic Boolean networks, can mimic processes involved in cellular decisions, such as stochastic switching of transcription factors (TFs) that represent cellular decisions (Heinäniemi et al. 2013) . In practice, dynamic simulations and modeling efforts are limited to small systems in which prediction can be easily verified (Choi et al. 2012) . Notably, none of these techniques permit multisystem genome-scale dynamic simulations of disease processes, due to uncharacterized genetic and molecular dynamics-related parameters, computational limitations and a paucity of biomarkers for intermediate phenotypes (Przytycka et al. 2010) .
Gene coexpression networks offer genome-scale information and also have the potential to highlight specific molecular mechanisms in disease -particularly if the biophysical basis of coexpression is integrated into network analysis and if researchers examine network properties beyond modules and hubs. For instance, it is common to use coexpression links to identify highly connected genes ('hub genes') that are also disease-correlated, as putative mediators of pathology. While this approach has led to many valuable insights, it tends to focus attention on a few hub genes, and ignores the many other ways in which coexpression networks can be used to generate and translate systems biology insights into testable predictions. Coexpression networks have such tremendous potential because gene-gene correlations relate to core features of brain activity and structure, including spatial patterning, inter-tissue communication and epigenetic changes and other non-coding features of regulatory networks (Fig. 1) . The aggregation of multiple regulatory features into a single network provides a powerful tool to investigate cellular dysfunction, which can be traced back to deficits in specific molecular mechanisms, cell-types or inter-regional communication (Figs. 2,3 ).
Basics of gene-gene coexpression links
When the mRNA expression of two or more genes is correlated across multiple samples, these genes are said to be 'coexpressed' (Fig. 2) . These coexpression links are generally inferred from large microarray or RNA sequencing studies with no reference to the mechanisms behind these correlations. Studies in multiples species, tissues and platforms have shown that coexpressed genes tend to be functionally related (Obayashi et al. 2008; Oldham et al. 2006) . Analogously, gene sets that are densely interconnected by coexpression links within the global gene network are commonly known as clusters or 'modules' (Fortunato 2010; . If a significant fraction of genes in a module relate to a gene ontology category or canonical pathway, through guilt-byassociation (GBA) the remaining genes in the module are assumed to be related to that function (Gillis & Pavlidis 2012; Wolfe et al. 2005) . Thus a modular approach to gene function may circumvent knowledge limitations of biological databases that simply catalog items, although existing bias in ontology databases may still affect genenode classification. Numerous studies have applied gene coexpression network analysis to associate coexpression modules with brain and psychiatric diseases De Jong et al. 2012; Ponomarev et al. 2012; Torkamani et al. 2010; Voineagu et al. 2011; Zhang et al. Various biological activities (depicted in outer shapes) can influence the expression of two or more genes and yield correlated expression patterns, denoted as 'coexpression links'. Hence coexpression links reflect the converging influences of these genetic, biochemical and environmental factors, and are thus informative of the biological state of an individual. The relative proportion of links from these various sources (depicted by small arrows) has not been surveyed in a consistent experimental system, and may vary for each gene. Furthermore, technical and cell-type variability can easily generate correlated expression patterns which are indistinguishable from 'biological' sources of coexpression, such as epigenetic regulation. Therefore, when interpreting coexpression networks, it is helpful to separate gene-gene correlations with likely biological origins vs. those which are related to overarching technical factors such as batch effects. 2013). Ironically, the practical utility of coexpression networks for identifying novel disease modules -for instance coexpression hubs within disease-associated modules -has pushed the molecular-mechanistic basis of coexpression into the background. By opening the 'black box' that generates coexpression modules, it is possible to identify novel molecular mechanisms that are relevant to disease.
Interpreting coexpression networks that are composed of thousands of gene-gene correlations is challenging because these correlations can arise from several biological and non-biological sources that are mathematically indistinguishable (Fig. 1) . Any mechanism that synchronously regulates transcription of multiple genes may potentially generate coexpression relationships. For instance, TFs have unique DNA binding sites located in promoter regions of distinct sets of genes, and are hypothesized to be a major source of correlated gene expression (Allocco et al. 2004; Marco et al. 2009 ). The highly structured spatial configuration of chromosomes (Lieberman-Aiden et al. 2009 ) is an Gene expression patterns can change in several ways between control and disease samples, beyond standard differential expression (purple line). The variance of a gene's expression may be altered in disease with or without differential expression (red gene expression profile; Ho et al. 2008) . Similarly, altered gene-gene correlations in disease can occur with or without changes in expression (Hudson et al. 2009) . A potential mechanism mediating the loss of gene-gene correlations in the disease state, through disrupted transcription factor binding, is shown on the right. important determinant of gene expression patterns, through chromosome maps and transcriptional complexes (Homouz & Kudlicki 2013) . The linear sequence of DNA can also influence coexpression patterns, as polymerase binding may lead to synchronous transcription of several genes (Ebisuya et al. 2008) . mRNA degradation may additionally play a role in observed coexpression networks, and pairs of miRNAs can themselves be coexpressed (Baskerville & Bartel 2005; Dong et al. 2010 ) and covary with their targets (Bandyopadhyay & Bhattacharyya 2009; Gennarino et al. 2012) . Histone acetylation and methylation control gene expression on multiple segments of DNA and can contribute to coexpression of neighboring genes Numata et al. 2012) .
In addition to these biophysical sources of expression variation, technical effects such as batch processing and RNA quality can produce non-biologically driven coexpression patterns and modules. Even when the exact source of systematic variation in microarrays is unknown, it is now common practice to identify and regress out the effects of such latent variables out of the gene expression dataset (Leek & Storey 2007) . These latent variables may be distinguished from biophysically coexpressed modules, in that they will account for a significant proportion of overall expression variance, but will not be associated with specific biological functions (as denoted by enrichment in annotations corresponding to functional categories). Removal of other covariates from the expression matrix depends on the biological goal of the analysis. For instance, up to 10% of all genes display age-correlated expression changes (ErrajiBenchekroun et al. 2005) , so if the disease contrast is not age-related, it may improve results to remove the covariate of age, but if aging is a suspected component of the disease of interest, then it should not be removed.
Another source of coexpressed genes relates to the cellular admixture of the sampled tissue. Coexpression datasets which are not acquired from single cell populations -which is the case for the majority of brain datasets -must confront the influence of cellular heterogeneity on gene coexpression. Unmeasured cellular heterogeneity has both confounding and useful effects. If several cell-types are combined in a sample and the proportion of these celltypes varies randomly across samples, then it is possible to produce coexpression modules which are not driven by ongoing biophysical properties, but by variation in markers for various cell-types. This may create cell-type specific modules associated with oligodendrocytes, microglia and several classes of neurons (Hawrylycz et al. 2012; Oldham et al. 2008) , as coexpression links within these modules are often driven by the covariance of cell-type markers. Accordingly, spatial patterns of gene expression across brain regions reflect the changes in cellular composition in addition to cell-based changes in transcriptional programs (Hawrylycz et al. 2012; Menashe et al. 2013 ). On the other hand, synchronous expression patterns across spatially separated brain regions (Gaiteri et al. 2010) , or between a brain region and peripheral organs (Dobrin et al. 2009 ), may also indicate the presence of cross-tissue communication, likely mediated by circulating factors. Because systemic diseases such as diabetes and obesity can also affect the function of several brain regions and risk of Alzheimer's disease, these crosstissue coexpression links may provide novel observations on the spread of pathology. Unfortunately, multitissue datasets are rare due to high cost; however, the Genome-Tissue Expression (GTEx) project data extracted from 30 tissues may expose novel multi-organ network (Lonsdale et al. 2013) . 
Differential coexpression represents altered regulatory network structure
Differential coexpression refers to changes in gene-gene correlations between two sets of phenotypically distinct samples (Figs. 2,3) (De La Fuente 2010). Changes in gene-gene correlation may occur in the absence of differential expression, meaning that a gene may undergo changes in regulatory pattern that would be undetected by traditional differential expression analyses. This phenomenon has been shown in aging (Southworth et al. 2009 ), across corticolimbic regions in major depression (Gaiteri et al. 2010 ) and between miRNA's in Alzheimer's disease (Bhattacharyya & Bandyopadhyay 2013) . While tests for differential expression must be statistically corrected for the large number of genes measured by microarray, results from differential coexpression must endure a more extreme statistically correction, because identifying altered correlations involves a comparison between two matrices of pair-wise gene-gene correlations. Therefore it is sometimes useful to estimate aggregate differential expression on a gene-by-gene or module-by-module basis, to reduce the number of statistical tests, and to check for coherent correlation changes within a particular molecular system in the disease state (Amar et al. 2013; Kostka & Spang 2004) .
In the same way that regulatory patterns within tissues may be altered across phenotypic states in manners that are reflected in altered coexpression networks, crosstissues communication can be monitored via coexpression networks. For instance, a core feature of major depression is abnormal feedback between the amygdala and anterior cingulate cortex, mediating emotional reactivity (Kupfer et al. 2012) . A study of gene coexpression across these two regions showed that more genes gained or lost coexpression links than expected at random, when comparing crosstissue networks from post-mortem tissue of patients with major depression to healthy controls (Gaiteri et al. 2010) , suggesting an orchestrated transcriptional reorganization affecting this neural network. In this particular example, biological pathways corresponding to the identified gene set suggested dysregulated functions for several hormonetype factors previously implicated in depression (insulin, interleukin-1, thyroid hormone, estradiol and glucocorticoids), indicating the presence of a distinct and integrated hormonemediated corticolimbic homeostatic, although maladaptive and pathological, state in major depression. Hence, changes in coordinated gene expression across brain areas may represent a novel molecular probe for brain structure/function that is sensitive to disease condition.
Hubs and coexpression network topology
The structure of coexpression networks has particular properties that are relevant to the function of regulatory networks and disease resilience. Coexpression networks meet the definition of 'small-world' networks (Watts & Strogatz 1998) because they are highly clustered (connected nodes have common neighbors) yet maintain an overall short path length, meaning signals can traverse the entire network in only a few hops. The ability to efficiently transit within and between clusters is facilitated by 'hubs', which are connected to a large number of nodes. Hub genes have both theoretical and practical implications for coexpression networks. From a theoretical perspective, information flow through small-world, scale-free networks is unlikely to be affected by random node deletion, but is especially vulnerable to targeted hub attack (Albert et al. 2000) . In a disease context, this is termed the 'lethality-centrality' relationship (Jeong et al. 2001) and is supported by examples from multiple molecular and brain networks in which hub targeting leads to crucial functional impairment (Stam et al. 2007 ). Practically, hubs provide a specific focus for investigations into disease-correlated modules of genes (next section), Ray et al. 2008; Torkamani et al. 2010; Voineagu et al. 2011 ). However, restricting experimental attention to coexpression hubs may discount other relevant molecules and is no guarantee of phenotypic effects, as coexpression links may represent a variety of causal or non-causal interactions (Fig. 1) .
Modules as functional markers of network activity
A 'module' refers to a gene set whose expression patterns are mutually correlated . Just as correlated genes tend to have similar biological functions, on a larger scale, modules tend to contain genes with similar biological functions (Lee et al. 2003) (Fig. 3) . Module membership can be compared between cases and controls, among different tissues, species, or other phenotypes or clinical traits (Cai et al. 2010; Kang & Kawasawa 2011) . Typical analysis of gene coexpression seeks to associate coexpression modules with disease or other phenotypic traits recorded in the same dataset. For instance if the average expression of a particular module is higher in patients with more severe pathology, then the activity of genes in that module is potentially linked to that pathological trait. While it would be desirable to identify causal molecular systems behind pathology, the trait-module association may be a downstream effect of the pathology. Module-trait correlation values tend to be relatively low (R < 0.5), but statistically significant because they are sustained across hundreds of genes (Zhang et al. 2013) . Moreover, the fraction of genes in a module relating to its main biological function is often under 20%, indicating modules contain diverse functions with a multidimensional relationship to measured traits. Thus a modular coexpression analysis can potentially highlight novel disease-relevant genes through GBA, but in reality modules are a complex mix of molecular functions (Gillis & Pavlidis 2012 ) with limited, but hopefully robust, correlations to clinical traits (Langfelder et al. 2013) .
A plethora of methods can identify putative coexpression modules (Fortunato 2010; Jay et al. 2012; . Choosing the 'best' clustering method is a balance between the mathematical ability to detect locally dense modules, the biological ability to find functionally enriched clusters and computational efficiency. Thus, depending on the data size and biological goals, the best method for a particular dataset may vary (Vega-Pons & Ruiz-Shulcloper 2011). However, all clustering results can be evaluated through statistics on their reproducibility under data resampling and ability to find locally dense clusters (Fortunato 2010) . While clustering methods attempt to minimize links between modules, thousands of such links remain after clustering, which would be expected given the overlapping regulatory domains of systems that generate coexpression (Figs. 1,3) indicating that the concept of functionally and structurally independent modules is a convenient simplification of the structure of gene-gene correlations.
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Coexpression networks provide a contextual biological framework for both discovery-and hypothesis-driven research with the goal of highlighting unifying features of suspected disease genes (Gulsuner et al. 2013) . While many coexpression studies incorporate elements of gene modules and hubs, some studies have now advanced substantially beyond them to address the diverse biophysical sources of coexpression (Fig. 1) , additional coexpression-based changes in disease such as differential coexpression (Fig. 2) , or use experimental work to validate the predictions of coexpression networks, and incorporate systems biology perspectives to clarify the complex bases of brain diseases (Fig. 3) . To highlight this emerging potential and provide concrete examples of the complex questions and challenges that coexpression networks can address, we briefly discuss several key findings that have emerged from studies using coexpression networks in novel ways.
Changes in coexpression network structure identify candidate disease genes Gene-gene correlations may be altered in disease and signal altered regulatory structure (Fig. 2) without affecting differential expression (see section on differential connectivity). While differential coexpression is itself a novel tool, it is generally applied to find entire modules of genes with different connectivity (correlations) in the disease state (Zhang et al. 2013) . Expanding on previous work in differential coexpression (Hudson et al. 2009 ), Rhinn et al. (2012) show how differential coexpression can be used to prioritize disease-related molecular targets. The alpha synuclein variant 'aSynL', containing a long 3 UTR, was identified as the most differentially coexpressed gene in several Parkinson's disease datasets; however, aSyl was not highly differentially expressed and thus would have likely been overlooked by traditional microarray analysis. Notably, all datasets used in that study to select and investigate aSynL are publically available, indicating that differential coexpression is an accessible and applicable technique for existing brain disease microarray data.
Coexpression networks track brain region differences and disease vulnerability
Integrating coexpression results with related datasets can increase the statistical confidence in the findings and show how these networks (which may include dozens of modules and hundreds of hub genes) fit within the broader context of research. Miller et al. (2013) enhance their within-subject comparison of CA1 vs. CA3 vulnerability during the progression of Alzheimer's disease with statistical comparisons to related studies. These comparisons include module-module overlaps to other coexpression studies, rank-order comparisons to other differential expression studies and integration of cell-type signatures, all of which contribute to a high-confidence set of disease genes and systems biology hypotheses of how region-specific expression relates to specific measures of Alzheimer's disease progression and cell-type specific properties. This study illustrates that even when the primary dataset contains multiple brain regions, it is possible to substantially enhance the hypothesis generation from coexpression networks through integration of public data.
Coexpression networks unify heterogeneous molecular deficits in rare diseases Gulsuner et al. (2013) provide a demonstration of how coexpression networks are useful in this context of highly heterogeneous pathology, by unifying de novo schizophreniaassociated mutations into more coherent mechanisms, in part by the coexpression relationships of the genes which harbor these mutations. They inferred coexpression relationships between genes using a pseudo time-series of 26 brains from a period of human development spanning 13 weeks of age to early adulthood in the Brainspan: Atlas of the developing human brain (www.brainspan.org). Then they counted the number coexpression and protein-protein interaction links between genes harboring these mutations and found a greater number of links than expected using sibling controls, with the most extreme difference found in the frontal cortex comparison. This indicates that mutated genes gain correlations in the disease state, and that disease state is not accompanied purely by loss of function at the coexpression level. By mapping a different data type (i.e. DNA sequences) directly to gene-gene correlations, this study shows how the apparently sporadic set of genes related to schizophrenia affect coherent molecular functions.
Differentially expressed genes in some complex psychiatric diseases have low connectivity
In earlier work, we established that gene coexpression network topology, demonstrating both small-world and scalefree characteristics, is resilient to changes in diseased subjects across multiple brain regions (Gaiteri and Sibille 2011) . As hub nodes are particularly vulnerable to perturbations in small-world networks, and standard pathological mechanisms for small-world networks involve attacks on central hubs, the finding that differentially expressed genes primarily reside on the periphery of coexpression networks for neuropsychiatric disorders such as depression, schizophrenia and bipolar disorder was surprising, but consistent with the heterogeneous nature of these disorders. The low connectivity of differentially expressed genes suggests that modulating a single gene, or even category of genes, is likely to have a limited therapeutic effect, perhaps accounting for the low efficacy of current antidepressant treatments and providing a rationale for a treatment comprising a rational combination of mechanism-supported drugs.
Cross-tissue coexpression relationships affect brain gene expression
As shown in Dobrin et al. (2009) , tissue-to-tissue coexpression networks can quantify inter-tissue interactions, even across the blood-brain barrier. Using microarrays from hypothalamus, liver and adipose tissue, they found that 40% of gene-gene correlations relate to cross-tissue interactions.
Thus these cross-tissue interactions may account for a significant fraction of coexpression in other studies, but these contributions go undetected because peripheral tissues are not assessed simultaneously. This multitissue approach also has the potential of identifying more easily accessible peripheral regulators of brain processes. In this way, the structure of cross-tissue networks can be a hypothesis generator for diseases with suspected endocrine or inflammation involvement that would potentially synchronize gene expression across tissues and organs.
Practical coexpression network analysis, part 2: answers to common questions from experimental biologists How many samples do I need for coexpression analysis?
The number of samples required for useful coexpression analysis depends on the genetic and environmental heterogeneity of the samples, their technical quality and the molecular severity of any disease contrasts. For instance, building coexpression networks from post-mortem brains of subjects with psychiatric disorders can be challenging because medication history and disease severity/onset are generally difficult to establish. Constructing networks from samples of pure cell populations or from mice of common genetic background allows coexpression networks to be constructed with fewer samples. Such pure cell populations will still have expression variation due to endogenous regulatory patterns (Basso et al. 2005; Clarke et al. 2011) or developmental regulation (Konopka et al. 2012) . Networks inferred in culture systems avoid the confounding effects of opposite expression patterns that may occur in different cell types -which are intermingled in typical post-mortem brain samples.
For small sample sizes (∼n < 20) it may be helpful to use robust correlations measures such as spearman's correlation or the biweight correlation (Song et al. 2012) which limit the impact of a small set of outlying expression datapoints, that might drive high Pearson correlations, when the majority of datapoints are uncorrelated. However, as the number of samples increases, the strongest correlations identified by these robust methods become very similar to those identified by Pearson correlation. In order to identify differentially coexpressed links or genes, it is necessary to have sufficient samples for high-confidence network construction in each phenotype.
What about non-linear molecular interactions? Are those detected?
While early microarray analyses relied on Pearson correlation in part because it is very fast to compute, new efficient routines to compute all pair-wise mutual information and biweight correlations make it possible to test for non-linear relationships that are robust to outliers. Fortunately it appears that results from non-linear tests are dominated by linear relationships (Song et al. 2012 , Steuer et al. 2002 . Thus, if the strongest gene-gene interactions are prioritized to create coexpression networks, both linear and non-linear approaches tend to select similar set of interactions.
How do I know that gene modules are biologically real?
There are both statistical and biological approaches to the validity of gene expression modules. Statistical approaches focus on module reproducibility, while biological test of gene modules focus on the ability to consistently perturb entire gene modules. From a statistical perspective, if gene modules are not reproducible between similar cohorts or orthologous datasets, then the conclusions from coexpression analysis will not generalize. Therefore, it is important to quantify the reproducibility of gene-gene correlations and gene modules across multiple datasets. The gene-gene correlations that give rise to modules persistent across arrays, normalization procedures and species, making technical artifacts unlikely, as such effects are randomized across datasets (Obayashi et al. 2008) . Within single datasets, spurious clusters can be generated if batch effects are not controlled (Leek & Storey 2007) , which might lead to spurious modules that will not be reproduced in other studies. While coexpression module might be expected to be more robust than specific gene-gene correlations, the process of generating modules may introduce noise because modules are highly overlapping and difficult to optimally define. For instance, if the clustering algorithm used to define gene modules is sensitive to various thresholds, this may also lead to 'unstable' module definitions. It is possible to avoid this clustering instability by resampling the expression dataset and re-identifying modules many times to identify genes which robustly cluster together. This critical step to ensure module reproducibility is often skipped because some clustering algorithms take hours to generate a single set of gene modules.
Direct estimate of the reproducibility of modules across similar data sets, are rare, although a lone example from glioblastoma research supports ∼50% overlap (Ivliev et al. 2010) , which equates to extreme p-values for reproducibility. In the context of cross-species comparisons, this may be quite impressive , Oldham et al. 2006 , but in the context of replicate cohorts which are expected to have similar results, it represents a high level of variability. The very concept of distinct modules is an intrinsic limitation to reproducibility, as there are many coexpression links between modules (Fig. 3) . To avoid the instability in clustering results due to overlapping modules it may be useful to employ clustering methods which produce overlapping clusters (Evans & Lambiotte 2009) or methods that combine clusters from multiple techniques, harnessing diverse results to provide both robustness and unique insights. However the optimal way to define 'consensus' modules based on the output of multiple clustering is an open mathematical question of equal complexity to the original clustering problem (Vega-Pons & Ruiz-Shulcloper 2011).
While statistical techniques can prove that modules are coregulated, 'biologically real' also implies it is possible to operate on gene sets as units. To demonstrate biological coherence of a module, the effects of a perturbation should primarily be constrained to the genes within that module. Coexpression modules are not in fact completely modular -there are many correlations among the members of different modules. Therefore the effects of a perturbation may extend outside of a module, but should still be predicted by the network structure as in Zhang et al. (2013) . The Connectivity Map (Lamb et al. 2006) and DrugMatrix (Natsoulis et al. 2008 ) databases offer libraries of perturbation microarrays, and indeed contain coexpressed modules that are generated by certain classes of drugs (Iskar et al. 2013) , which indicates that perturbations tend to result in reproducible and bounded coexpression effects.
Do coexpression modules predict disease or disease severity?
If coexpression patterns are robustly related to cellular pathways activated in disease states, it would seem to follow that modules and hub gene expression should robustly predict disease status or severity. Many authors have noted the partial overlap between disease-associated coexpression hubs and known disease modulators or GWAS hits De Jong et al. 2012; Ponomarev et al. 2012; Torkamani et al. 2010; Voineagu et al. 2011; Zhang et al. 2013) . But the average correlation of coexpression modules with disease traits, is often less than R = 0.5 (Zhang et al. 2013 ) although module-disease correlations are highly significant, as they are sustained across hundreds of genes. Another way to assess the predictive power of modules is by tracking the reproducibility of hub-disease correlations across replicate datasets, compared to standard meta-analysis for biomarker discovery. This comparison shows traditional meta-analysis techniques generally output more reproducible disease-correlated gene lists, except when hubs are carefully selected and the overall differential expression is weak (Langfelder et al. 2013) . In these noisy cases, the redundancy inherent in coexpression networks helps to improve reproducibility compared to traditional measures. Therefore, while coexpression networks are a useful framework to drive experimental programs, their predictive performance on a module-bymodule level makes it challenging to use them as disease classifiers.
In light of these relatively low module-disease correlations, various robust regression and machine learning approaches likely offer better performance in classifying the disease status of microarray samples (Pirooznia et al. 2008) . In contrast to coexpression approaches, which highlight the covariance structure of gene expression, common machine learning approaches tend to choose a single or small number of genes to exemplify correlated gene sets (Zou & Hastie 2005) . While machine learning techniques do not automatically place disease-associated molecules in a coherent biological framework, they can identify a limited set of predictive gene-features, which can be submitted for gene set enrichment analysis. The debate between coexpression vs. disease biomarker detection goes beyond mathematical assessments, because these techniques generally take different scientific roles. The way in which coexpression networks reflect endogenous regulatory systems may set the stage for detailed set of molecular experiments that occur in a coherent molecular system, as in Rhinn et al. (2012) . However, results from coexpression analysis are potentially less suited for identifying single-gene disease biomarkers (Langfelder et al. 2013) . Thus while coexpression modules are significant predictors of disease, they are rarely used as pure predictors of disease and face a significant challenge from machine learning techniques in the search for biomarkers.
While machine learning and coexpression approaches to predicting gene expression have traditionally arisen from different conceptual approaches to biology, a rare example of the potential for hybrid approaches, the algorithm, Ontogenet, predicts major regulators associated with cell-types specific expression, using a combination of coexpression modules, machines learning inference and molecular interaction databases (Jojic et al. 2013) . The results offer superior predictive performance vs. elasticnet (Zou & Hastie 2005 ) (a popular pure machine learning approach) while offering a more specific list of module regulators than is available by pure coexpression approaches. While such novel hybrid approaches are highly novel and have not been applied to brain disease datasets, they show an opportunity of maximize the predictive power and interpretability of coexpression modules.
How do you create network images?
Network visualization is an important step that allows researchers to intuitively explore the network topology and develop hypotheses. Cytoscape (Shannon et al. 2003 ) is a flexible and widely used software platform for visualizing networks and biological pathways and integrating these networks with annotations, gene expression profiles and other data. It also contains various analysis tools as plugins that were contributed by other labs. Other visualization tools to illustrate biological networks include VisANT (Hu et al. 2005) , Pajek (De Nooy et al. 2005) and Gephi, and others reviewed elsewhere (Pavlopoulos et al. 2008) . The choice of which visualization software to use depends on their ability to incorporate additional layers of biological information into network properties, such as node size and color (both Gephi and Cytoscape offer this extensively) as well as node layouts, which can radically alter the reader's perception of networks. Unfortunately there is no generally optimal biological node layout; therefore it is helpful to rapidly try several layouts to determine an informative networks layout, as the base layer for additional node properties, node groupings, labels and experimental annotations.
It is challenging to visualize large and complex networks, because gene networks with thousands of dimensions are projected onto a 2D lane for publication, sometimes producing an uninformative 'hair ball' effect. Traditionally multidimensional scaling (MDS), accessible in various Rpackages, is used to visually maximize the distinctions between clusters . More recent approaches to visualizing networks of thousands of nodes such as Biofabric give a new simple two dimensional line representation of the networks with additional clarity with row lines representing nodes and column lines representing links (Longabaugh 2012) , which allows a scalable and unambiguous presentation of the network edges. Another alternative network representation is the 'hive plot', which positions nodes on radically distributed axes based on network structural properties (Krzywinski et al. 2012) .
Emerging topics and key issues for future coexpression network research
Comprehensive species, tissue and disease catalog of coexpression modules
Comparisons of module membership across many datasets may increase confidence in the biological reality of modules and show novel cross-tissue communication, or similarities between modules found in different diseases. The basis for such a comparison would be a user-driven database of gene lists and their module assignments, annotated by tissue-type and disease status. These lists can be compiled even when the complete expression data is not publically available or restricted. Primary use cases would be researchers querying against the database for modules robustly associated with a given phenotype, or for overlap between their clustering results and all modules in the database. Such a database would include popular WGCNA-based results ), but also allow inputs from many clustering algorithms, which would further verify the existence of robustly correlated gene sets.
Identifying recurrent patterns across multiple networks could reveal important functional associations and increase the accuracy rather than focusing on single study analysis where random pattern could occur due to spurious correlations. A straightforward way to aggregating studies is simply to concatenate the gene expression matrices as in (Dunker et al. 2001; Mabbott et al. 2010) or to combine the evidence of gene interaction by vote counting or Fisher's methods (Cancer Genome Atlas Research Network 2011; Niida et al. 2010 ). However, combining in those ways could introduce false patterns from normalization and nature of heterogeneity between studies. Therefore, directly detecting frequent patterns in multiple networks is likely a better solution (Li et al. 2011 ).
Annotating coexpression links via causal molecular mechanisms
Differential coexpression is likely related to altered generegulation (Fig. 2) , but in most cases the cause remains unknown. An ideal experiment to associate specific molecular mechanisms with differential coexpression would be to assess the regulatory structure of multiple systems in a disease model (Hudson et al. 2012 ). This would require multiple assays to be measured in pure cell populations, including chromosome interactions, ChIP-seq on at least several TFs, miRNA and methylation. Potential discoveries from this approach could determine if particular modules are generated predominantly by a single molecular mechanism, or if there are stereotypical inter-regulatory motifs (patterns of links between different regulatory systems, such as feedforward inhibition) that have not been previously shown, but have been shown to occur in other networks (Gerstein et al. 2012; Jothi et al. 2009; Ma'ayan 2009; Nazarov et al. 2013) . Specific molecular mechanisms associated with disease states could be assessed by combining multiple aforementioned high-throughput methods with coexpression network structure (Fig. 3e ).
Beyond hubs: mapping the connectivity of differentially expressed and disease genes If disease genes are characterized by a particular type of connectivity in molecular networks, it would be a powerful filtering mechanism to prioritize disease targets -simply examining the connectivity of various putative disease genes. Attempts to find such a disease-connectivity relationship suggest that if this relationship exists, it is sensitive to the definition of disease genes and molecular connectivity. For instance GWAS genes tend to be bottleneck nodes of high betweenness centrality in various networks and genes with common cancer mutations tend to be protein hubs (Jonsson & Bates 2006) . This suggests that centrality and overall connectivity in a network are associated with disease activity. However, OMIM (Online Mendelian Inheritance in Man) genes do not occur with a characteristic connectivity in protein-protein interaction networks (Goh et al. 2007 ) and monogenic disease genes tend to have connectivity that is tightly constrained around average values (Feldman et al. 2008) . Thus, different definitions of the set of disease genes can result in different conclusions about the expected connectivity of disease genes (hubs vs. exact average connectivity). In addition to the definition of the set of disease genes, the type of network in which disease gene connectivity is measured can affect the disease-connectivity relationship. For instance, differentially expressed genes in Parkinson's disease and schizophrenia tend to be hub nodes in protein networks (Mar et al. 2011) , while differentially expressed genes from schizophrenia, bipolar disorder and major depression tend to be low-connected in coexpression networks (Gaiteri & Sibille 2011) . Thus, when evaluating the 'meaning' of connectivity of a particular set of disease-related genes, it is useful to check the connectivity across multiple types of networks.
Disease severity may interact with molecular connectivity in such a way that places disease genes at different network locations. This interaction may explain some of the apparently conflicted results mentioned previously. Specifically, more severe diseases are associated with deficits in more central genes (Barrenas et al. 2009 ). Such a relationship could be tested in compiling differential gene expression signatures from diseases of varying severity/lethality and may be useful in understanding control mechanisms in complex diseases. The relationship of disease to network structure will likely be more complex than a linear relationship between the number of connections of disease-associated genes vs. disease severity (Park & Kim 2009 ). An example of a more complex network relationship that links connectivity to disease would be the way in which the severity of different cancers is related to the distribution of connectivity (known as degree heterogeneity) in KEGG pathways of all genes associated with a particular type of cancer (Breitkreutz et al. 2012) . The sensitivity of the link between connectivity and disease activity is a cautionary note against exclusive focus on hub nodes in coexpression networks as disease-mediators.
Coexpression in network pharmacology
Neuroscience drug development is challenging because brain function-level phenotypes are difficult to simulate through in vitro systems, while animal models of common diseases including schizophrenia, major depression and Alzheimer's disease do not generate the severe behavioral or molecular phenotypes of the human disease. Because coexpression networks encapsulate multiple molecular regulatory mechanisms in an unbiased manner, they may offer a framework to track connections between downstream disease effectors, to supply additional targets similar to existing targets that have been discarded for toxicology reasons or to indicate previously undetected aspects of pathology -for instance differential coexpression in the absence of differential expression (Csermely et al. 2013; Rhinn et al. 2012) . Coexpression may even be useful in organizing compound libraries from a systems biology perspective. Using the Connectivity Map (Lamb et al. 2006) and DrugMatrix (Natsoulis et al. 2008 ) databases of drugresponse microarrays from three human and one rat cell-line, Iskar et al. (2013) found reproducible coexpression modules that correspond to specific drug treatments. While finding coexpression patterns requires more samples than looking for differential expression among drug responses, it has the benefit of associating data-driven signaling pathways (coexpression modules) with each drug and identifying sets of drugs that activate related molecular systems.
However, the application of systems biology to drug discovery is impeded because most computational researchers do not have structures in place to perform validation experiments that 'prove' their methods are correct. This conflict between pursuing 'risky' experiments with no 'guarantee' of positive results and the need to move beyond the single-gene, single-disease model, presents opportunities for coexpression analysis. There is no reason to limit network exploration purely to coexpression, but coexpression links should be compiled alongside protein-protein interactions, TF-binding, miRNA targets, chromosome contact maps into 'meta-networks' which have been shown to collectively direct cellular activity (Gerstein et al. 2012; Ma'ayan 2009) . If the structure of networks in this hybrid database is compared to perturbation experiments, this would form the basis of new predictive methods to control target gene sets identified in human disease samples (Csermely et al. 2013; Hopkins 2008) and to potentially identify critical regulatory elements hidden in gene coexpression networks as novel targets.
